<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v3.0 20080202//EN" "archivearticle3.dtd"><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?DTDIdentifier.IdentifierValue article.dtd?><?DTDIdentifier.IdentifierType system?><?SourceDTD.DTDName article.dtd?><?SourceDTD.Version 1.0?><?ConverterInfo.XSLTName bmc2nlmx2.xsl?><?ConverterInfo.Version 2?><front><journal-meta><journal-id journal-id-type="nlm-ta">BMC Med Genet</journal-id><journal-title-group><journal-title>BMC Medical Genetics</journal-title></journal-title-group><issn pub-type="epub">1471-2350</issn><publisher><publisher-name>BioMed Central</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">1471-2350-11-18</article-id><article-id pub-id-type="pmid">20122156</article-id><article-id pub-id-type="doi">10.1186/1471-2350-11-18</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research article</subject></subj-group></article-categories><title-group><article-title>Genetic selection? A study of individual variation in the enzymes of folate metabolism</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes" equal-contrib="yes" id="A1"><name><surname>Jennings</surname><given-names>Barbara A</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>b.jennings@uea.ac.uk</email></contrib><contrib contrib-type="author" equal-contrib="yes" id="A2"><name><surname>Willis</surname><given-names>Gavin A</given-names></name><xref ref-type="aff" rid="I2">2</xref><email>gavin.willis@nnuh.nhs.uk</email></contrib><contrib contrib-type="author" id="A3"><name><surname>Skinner</surname><given-names>Jane</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>jane.skinner@uea.ac.uk</email></contrib><contrib contrib-type="author" id="A4"><name><surname>Relton</surname><given-names>Caroline L</given-names></name><xref ref-type="aff" rid="I3">3</xref><email>c.l.relton@ncl.ac.uk</email></contrib></contrib-group><aff id="I1"><label>1</label>School of Medicine, Health Policy and Practice, University of East Anglia, Norwich NR4 7TJ, UK</aff><aff id="I2"><label>2</label>Department of Molecular Genetics, Norfolk and Norwich University Hospital, Norwich NR4 7UY, UK</aff><aff id="I3"><label>3</label>Institute for Ageing and Health and Human Nutrition Research Centre, Newcastle University, Royal Victoria Infirmary, Newcastle upon Tyne, NE1 4LP, UK</aff><pub-date pub-type="collection"><year>2010</year></pub-date><pub-date pub-type="epub"><day>1</day><month>2</month><year>2010</year></pub-date><volume>11</volume><fpage>18</fpage><lpage>18</lpage><history><date date-type="received"><day>2</day><month>6</month><year>2009</year></date><date date-type="accepted"><day>1</day><month>2</month><year>2010</year></date></history><permissions><copyright-statement>Copyright &#x000a9;2010 Jennings et al; licensee BioMed Central Ltd.</copyright-statement><copyright-year>2010</copyright-year><copyright-holder>Jennings et al; licensee BioMed Central Ltd.</copyright-holder><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/2.0"><license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/2.0">http://creativecommons.org/licenses/by/2.0</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><self-uri xlink:href="http://www.biomedcentral.com/1471-2350/11/18"/><abstract><sec><title>Background</title><p>Genetic variation in folate metabolism has been associated with survival <italic>in utero</italic>, the success of <italic>in vitro </italic>fertilisation, multiple pathologies and longevity.</p></sec><sec><title>Methods</title><p>We have looked at the prevalence of genetic variants of the enzymes MTHFR and TYMS in 2,898 DNA samples derived from five cohorts collected in the United Kingdom. The simultaneous analysis of genetic variants of the <italic>MTHFR </italic>and <italic>TYMS </italic>loci was carried out to investigate a putative gene-gene interaction that was first observed in an elderly male population from Norfolk.</p></sec><sec><title>Results</title><p>We have made a consistent observation in five population cohorts; the proportion of individuals who are homozygous for the 2R allele of the 5'UTR <italic>TYMS </italic>polymorphism is less in individuals who are homozygous for the T allele of <italic>MTHFR </italic>677 than in individuals homozygous for the C allele of <italic>MTHFR </italic>677 (p = 0.02).</p></sec><sec><title>Conclusions</title><p>These data may suggest a gene-gene interaction and could be evidence of genetic selection, with some pregnancies more or less viable as a consequence of genetic variation. If these genetic phenomena affect the way folate is handled at the cellular level <italic>in utero </italic>it is possible that maternal folic acid intake may over-ride such genetic selection.</p></sec></abstract></article-meta></front><body><sec><title>Background</title><p>Folate-dependent one-carbon metabolism is essential for nucleotide synthesis, methionine synthesis and for DNA methylation and depends on a number of enzymes that are functionally polymorphic. SNPs and other polymorphisms of the genes <italic>MTHFR</italic>, <italic>MTRR </italic>and <italic>TYMS </italic>have been associated with cardiovascular disease, neural tube defects, Down syndrome and leukaemia [<xref ref-type="bibr" rid="B1">1</xref>-<xref ref-type="bibr" rid="B4">4</xref>]. Adequate dietary folate, and its efficient metabolism have well-established roles in disease prevention; deficiency is associated with increased risk of neural tube defects, vascular disease, cancer and anaemia [<xref ref-type="bibr" rid="B5">5</xref>].</p><p>Proposals for the mandatory fortification of flour with folate in the United Kingdom are driven by the importance of this B vitamin to the development of the early embryo [<xref ref-type="bibr" rid="B6">6</xref>]. Embryo development and viability has been the subject of many epidemiological studies of genetic variants, including, and possibly predominantly, in those genes involved in folate metabolism [<xref ref-type="bibr" rid="B2">2</xref>-<xref ref-type="bibr" rid="B4">4</xref>,<xref ref-type="bibr" rid="B7">7</xref>]. B-vitamin status and folate metabolism have been shown to influence the outcome of <italic>in vitro </italic>fertilisation (IVF) [<xref ref-type="bibr" rid="B8">8</xref>,<xref ref-type="bibr" rid="B9">9</xref>]. Women who are homozygous for a variant of the gene <italic>MTHFR </italic>(1298A&#x0003e;C) were less likely to produce a live-birth than other women undergoing IVF and the chances of a twin birth increased with plasma and red cell folate concentrations [<xref ref-type="bibr" rid="B8">8</xref>]. The authors proposed that the woman's genotype is linked to her potential to produce good quality embryos and that this, coupled with folate status, increases the likelihood of IVF resulting in live births. Haggarty <italic>et al </italic>also observed an association between raised concentrations of homocysteine and an increase in the risk of miscarriage in their study of women undergoing IVF and elevated homocysteine levels has been linked recurrent pregnancy loss previously [<xref ref-type="bibr" rid="B10">10</xref>].</p><p>A meta-analysis has demonstrated that maternal hyperhomocysteinaemia (a metabolic consequence of low folate status) is associated with orofacial cleft and congenital heart defects [<xref ref-type="bibr" rid="B11">11</xref>], but the authors found no independent association between these congenital malformations and <italic>MTHFR </italic>genotype in either the mothers or children. However, the negative <italic>in utero </italic>effect of raised homocysteine has been proposed by Lucock and Yates as one of the mechanisms by which the genetic variant, <italic>MTHFR </italic>677C&#x0003e;T, compromises the viability of a pregnancy when dietary folate levels are inadequate [<xref ref-type="bibr" rid="B12">12</xref>]. These authors also hypothesise that when folate levels are unrestricted, there is a survival advantage <italic>in utero </italic>for homozygotes for the 677C&#x0003e;T allele because that genotype will increase the levels of 5,10 methylene tetrahydrofolate favouring DNA synthesis and stability. This hypothesis is supported by the authors of a recent study of the prevalence of this genotype in adult populations and in DNA samples taken from spontaneous abortions, they present evidence for the selection of the 677C&#x0003e;T allele associated with increased folate intake by women in the peri-conceptional period [<xref ref-type="bibr" rid="B13">13</xref>].</p><p>The <italic>MTHFR </italic>677C&#x0003e;T variant is associated with raised homocysteine concentrations and lower enzyme concentrations [<xref ref-type="bibr" rid="B14">14</xref>]. Association studies of the <italic>MTHFR </italic>677C&#x0003e;T variant and adverse pregnancy outcomes have in the main concluded that this variant is important in the pathogenesis of adverse pregnancy outcomes [<xref ref-type="bibr" rid="B15">15</xref>]. Less compelling evidence is available for <italic>TYMS </italic>genetic variants [<xref ref-type="bibr" rid="B16">16</xref>], one of which is a 5'UTR repeat variant (2R/3R) and the rare 2R variant is associated with lower TYMS expression and plasma homocysteine [<xref ref-type="bibr" rid="B17">17</xref>]. The simultaneous analysis of multiple genetic variants allows the consideration of additive, synergistic and compensating variants of folate metabolism. Disease association studies of two or more enzyme variants of folate metabolism are few, but suggest the possibility of gene-gene interactions or epistasis. One study has demonstrated a multiplicative effect on phenotype for the <italic>MTHFR </italic>677C&#x0003e;T and <italic>MTRR </italic>66G&#x0003e;A genotype combinations in relation to Down syndrome [<xref ref-type="bibr" rid="B4">4</xref>]. Another study demonstrated that three genotype combinations of the loci <italic>MTRR/FOLH1</italic>; <italic>MTHFR </italic>677/<italic>CBS </italic>and <italic>MTHFR </italic>677/<italic>MTRR </italic>increase the risk of neural tube defects [<xref ref-type="bibr" rid="B7">7</xref>].</p><p>A functional study of MTHFR and TYMS has shown that these enzymes compete for limiting supplies of folate required for homocysteine methylation [<xref ref-type="bibr" rid="B17">17</xref>]; which illustrates the likelihood that certain steps in one-carbon metabolism present bottlenecks for the distribution of folate species, and enzyme variants in these steps may be important.</p><p>We and others have previously found evidence for depletion of individuals homozygous for <italic>MTHFR </italic>677C&#x0003e;T relative to younger cohorts, and postulated it to be due to genotype-specific survival [<xref ref-type="bibr" rid="B18">18</xref>-<xref ref-type="bibr" rid="B20">20</xref>]. Because of observations made in cross-sectional population studies to explore the impact of genetic variants of the enzymes MTHFR and TYMS on survival in elderly cohorts, we have studied the prevalence of two polymorphisms in younger populations. The <italic>MTHFR </italic>and <italic>TYMS </italic>loci are found on chromosomes 1 and 18 respectively so linkage disequilibrium will not explain any digenic phenomena observed.</p></sec><sec sec-type="methods"><title>Methods</title><sec><title>Subjects</title><p>The polymorphic locus <italic>MTHFR </italic>677C&#x0003e;T and the 5'UTR repeat variant of <italic>TYMS </italic>(2R/3R) were co-analysed in 2,898 DNA samples from the following 5 population cohorts.</p><sec><title>Cohort 1</title><p>DNA extracted from 1178 blood samples collected from an elderly male population undergoing full blood counts in primary care or as patients at the Norfolk and Norwich University Hospital. Mean age = 84 years [range 70-99 years].</p></sec><sec><title>Cohort 2</title><p>DNA extracted from 438 blood samples collected from an elderly female population undergoing full blood counts in primary care or as patients at the Norfolk and Norwich University Hospital. Mean age = 92 years [range 89-104 years].</p></sec><sec><title>Cohort 3</title><p>DNA was extracted from 409 blood samples collected from a young female population undergoing full blood counts in primary care or as patients at the Norfolk and Norwich University Hospital. Mean age = 27 years [range 18-40 years].</p></sec><sec><title>Cohort 4</title><p>DNA was analysed from 398 blood samples from apparently healthy male volunteers recruited through a local community media-advertising campaign for a genetic and iron homeostasis study [<xref ref-type="bibr" rid="B21">21</xref>]. Mean age = 60 years [range 40-80 years]. The <italic>MTHFR </italic>data from this cohort has been described previously [<xref ref-type="bibr" rid="B22">22</xref>].</p></sec><sec><title>Cohort 5</title><p>DNA was obtained from 475 female volunteers from North Cumbria Community Genetics Project (NCCGP) [<xref ref-type="bibr" rid="B23">23</xref>]. Mean age of whole NCCGP cohort = 28 years [range 16-44 years].</p><p>Genotyping</p></sec><sec><title>DNA extraction and genotyping</title><p>High molecular weight DNA was sub-aliquoted onto 96 well plates at a concentration of approximately 100 ng/&#x003bc;l. All subsequent reactions were also performed in 96 well plates. The PCR reactions comprised of 100 ng DNA, 200 nmol/L of each primer and 1 &#x000d7; PCR Thermo Start Mastermix (ABgene UK, Epsom, England) in a 25 &#x003bc;l volume. The PCR conditions for each assay are shown in table <xref ref-type="table" rid="T1">1</xref>.</p><table-wrap id="T1" position="float"><label>Table 1</label><caption><p>Description of PCR Assays</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left"><italic>GENE</italic><break/>SNP I.D. or description</th><th align="left"><italic>MTHFR</italic><break/>rs1801133</th><th align="left"><italic>TYMS</italic><break/>5'UTR EX1+52CCGCGCCACTTC<break/>GCTGCCTCCGTCCCC</th></tr></thead><tbody><tr><td align="left"><bold>Rare allelic form</bold><break/><bold>(amino acid changes)</bold></td><td align="left">677C&#x0003e;T (A222V)</td><td align="left">2R<break/>[<xref ref-type="bibr" rid="B17">17</xref>]</td></tr><tr><td colspan="3"><hr/></td></tr><tr><td align="left"><bold>Sense primer and antisense primer</bold></td><td align="left">GGGTCAGAAGCATATCAGTCATG<break/><italic>CACAAAGCGGAAGAATGTGTC</italic></td><td align="left">AAAAGGCGCGCGGAAG<break/><italic>GCCGGCCACAGGCAT</italic></td></tr><tr><td colspan="3"><hr/></td></tr><tr><td align="left"><bold>Annealing temperature, cycle number</bold></td><td align="left">55&#x000b0;C, 38 cycles</td><td align="left">61&#x000b0;C, 38 cycles</td></tr><tr><td colspan="3"><hr/></td></tr><tr><td align="left"><bold>PCR product size in base pairs</bold></td><td align="left">326</td><td align="left">111 or 139</td></tr><tr><td colspan="3"><hr/></td></tr><tr><td align="left"><bold>Restriction enzyme (number of units) or size of ins/del</bold></td><td align="left">Hinf I (0.2), buffer 2</td><td align="left">28 bp repeat visible by gel electrophoresis</td></tr><tr><td colspan="3"><hr/></td></tr><tr><td align="left"><bold>Fragment sizes for common allele in base pairs</bold>.<break/><bold><italic>Fragment sizes for rare allele in base pairs</italic></bold>.</td><td align="left">104 and 222<break/>102, 166 and 53</td><td align="left">139<break/>111</td></tr></tbody></table></table-wrap><p>The <italic>MTHFR </italic>assay required restriction digestion prior to gel electrophoresis. 10 &#x003bc;l of PCR product was digested overnight at 37&#x000b0;<italic>Cina</italic>20 &#x003bc;l reaction volume. The enzyme and buffer used (New England Biolabs, Hitchin, UK) are described in table <xref ref-type="table" rid="T1">1</xref>.</p><p>The PCR products were electrophoresed on a 1 &#x000d7; Tris/Borate/EDTA, 3% Metaphor agarose (FMC Bioproducts, Lichfield, UK) gel in a stretch-wide apparatus (ABgene, Epsom, UK) at 80 V for 50 minutes.</p></sec><sec><title>Quality assurance</title><p>Gel analysis data were screened independently by two scientists (GW, BJ) and approximately 10% of the samples were genotyped a second time to check for concordance. A duplication of the <italic>MTHFR </italic>genotyping for 264 samples showed 100% concordance. A duplication of the <italic>TYMS </italic>genotyping for 362 samples showed 99.2% concordance and resulted in 3 reassigned genotypes. Furthermore, 4 samples that carried the rare 4 repeat allele were excluded from the analysis. The overall success rate for genotyping (in primary genotyping and re-analyses) was 99.6% for the <italic>MTHFR </italic>locus and 97.2% for the <italic>TYMS </italic>locus.</p><p>The samples from cohorts 1 to 4 were also genotyped for <italic>MTHFR </italic>1298 (rs1801131) and found to be in complete linkage disequilibrium with <italic>MTHFR </italic>677 as expected.</p></sec></sec><sec><title>Statistics</title><p>Hardy-Weinberg equilibrium (HWE); The &#x003c7;<sup>2</sup>-test was used to analyse the frequencies of genotypes detected for each locus and relative fitness ratios were estimated for homozygotes compared to heterozygotes.</p><p>We tested the hypothesis that the proportion of individuals homozygous for the 2R allele of the 5'UTR <italic>TYMS </italic>polymorphism was lower in the group homozygous for the T allele of <italic>MTHFR 677 </italic>than in the group homozygous for the C allele of <italic>MTHFR 677 </italic>using a one-sided Fisher's exact test for each population. We used Stouffer's consensus combined P-value test, as described and recommended in Rice (1990), which is designed to combine the P-values from a set of independent tests addressing the same hypothesis [<xref ref-type="bibr" rid="B24">24</xref>].</p></sec><sec><title>Ethics</title><p>Ethical approval for the study of anonymised DNA samples of groups 1 to 4 was obtained from Norwich and Waveney LREC. Ethical approval for the study of group 5 was obtained from Leeds West MREC.</p></sec></sec><sec><title>Results</title><sec><title>Genotyping</title><p>We have simultaneously determined the <italic>MTHFR </italic>677 and <italic>TYMS </italic>5'UTR genotype frequencies using DNA samples from 5 population cohorts comprising 2,898 individuals. The prevalence data and deviations from HWE are described in table <xref ref-type="table" rid="T2">2</xref> in addition to the relative fitness ratios for homozygotes compared to heterozygotes. Data are only presented for those samples that were successfully genotyped at both loci and which carried either the 2R or 3R allele at the <italic>TYMS </italic>locus.</p><table-wrap id="T2" position="float"><label>Table 2</label><caption><p>The <italic>MTHFR </italic>and <italic>TYMS </italic>genotype distributions, relative fitnesses and deviations from HWE of the genotypes in the 5 populations from Norfolk and Cumbria</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left"><italic>MTHFR</italic></th><th/><th align="center"><italic>CC</italic></th><th align="center"><italic>CT</italic></th><th align="center"><italic>TT</italic></th><th align="center"><italic>Relative fitness</italic><break/><italic>CC vs CT</italic></th><th align="center"><italic>Relative fitness</italic><break/><italic>TT vs CT</italic></th><th align="center"><italic>Deviation from HWE</italic></th></tr></thead><tbody><tr><td align="left">Cohort 1</td><td align="left">Observed</td><td align="center">486.0</td><td align="center">564.0</td><td align="center">128.0</td><td align="center">0.92</td><td align="center">0.85</td><td align="center">0.063</td></tr><tr><td/><td align="left">Expected</td><td align="center">500.7</td><td align="center">534.6</td><td align="center">142.7</td><td/><td/><td/></tr><tr><td align="left">Cohort 2</td><td align="left">Observed</td><td align="center">206.0</td><td align="center">191.0</td><td align="center">41.0</td><td align="center">0.98</td><td align="center">0.95</td><td align="center">0.824</td></tr><tr><td/><td align="left">Expected</td><td align="center">207.5</td><td align="center">187.9</td><td align="center">42.5</td><td/><td/><td/></tr><tr><td align="left">Cohort 3</td><td align="left">Observed</td><td align="center">179.0</td><td align="center">178.0</td><td align="center">52.0</td><td align="center">1.06</td><td align="center">1.11</td><td align="center">0.445</td></tr><tr><td/><td align="left">Expected</td><td align="center">175.6</td><td align="center">184.8</td><td align="center">48.6</td><td/><td/><td/></tr><tr><td align="left">Cohort 4</td><td align="left">Observed</td><td align="center">166.0</td><td align="center">202.0</td><td align="center">30.0</td><td align="center">0.81</td><td align="center">0.61</td><td align="center"><bold>0.003</bold></td></tr><tr><td/><td align="left">Expected</td><td align="center">179.1</td><td align="center">175.8</td><td align="center">43.1</td><td/><td/><td/></tr><tr><td align="left">Cohort 5</td><td align="left">Observed</td><td align="center">185.0</td><td align="center">214.0</td><td align="center">76.0</td><td align="center">1.08</td><td align="center">1.13</td><td align="center">0.287</td></tr><tr><td/><td align="left">Expected</td><td align="center">179.5</td><td align="center">225.0</td><td align="center">70.5</td><td/><td/><td/></tr><tr><td colspan="8"><hr/></td></tr><tr><td align="left"><bold><italic>TYMS</italic></bold></td><td/><td align="center"><bold>3_3</bold></td><td align="center"><bold>2_3</bold></td><td align="center"><bold>2_2</bold></td><td align="center"><bold>Relative fitness</bold><break/><bold>3_3 vs 3_2</bold></td><td align="center"><bold>Relative fitness</bold><break/><bold>2_2 vs 3_2</bold></td><td align="center"><bold>Deviation from HWE</bold></td></tr><tr><td colspan="8"><hr/></td></tr><tr><td align="left">Cohort 1</td><td align="left">Observed</td><td align="center">350.0</td><td align="center">541.0</td><td align="center">287.0</td><td align="center">1.16</td><td align="center">1.18</td><td align="center"><bold>0.007</bold></td></tr><tr><td/><td align="left">Expected</td><td align="center">326.8</td><td align="center">587.3</td><td align="center">263.8</td><td/><td/><td/></tr><tr><td align="left">Cohort 2</td><td align="left">Observed</td><td align="center">126.0</td><td align="center">216.0</td><td align="center">96.0</td><td align="center">1.02</td><td align="center">1.01</td><td align="center">0.848</td></tr><tr><td/><td align="left">Expected</td><td align="center">125.0</td><td align="center">218.0</td><td align="center">95.0</td><td/><td/><td/></tr><tr><td align="left">Cohort 3</td><td align="left">Observed</td><td align="center">129.0</td><td align="center">180.0</td><td align="center">100.0</td><td align="center">1.24</td><td align="center">1.28</td><td align="center"><bold>0.022</bold></td></tr><tr><td/><td align="left">Expected</td><td align="center">117.3</td><td align="center">203.5</td><td align="center">88.3</td><td/><td/><td/></tr><tr><td align="left">Cohort 4</td><td align="left">Observed</td><td align="center">124.0</td><td align="center">184.0</td><td align="center">90.0</td><td align="center">1.14</td><td align="center">1.16</td><td align="center">0.189</td></tr><tr><td/><td align="left">Expected</td><td align="center">117.2</td><td align="center">197.6</td><td align="center">83.2</td><td/><td/><td/></tr><tr><td align="left">Cohort 5</td><td align="left">Observed</td><td align="center">146.0</td><td align="center">240.0</td><td align="center">89.0</td><td align="center">0.96</td><td align="center">0.94</td><td align="center">0.641</td></tr><tr><td/><td align="left">Expected</td><td align="center">149.0</td><td align="center">234.1</td><td align="center">92.0</td><td/><td/><td/></tr></tbody></table><table-wrap-foot><p>Observed and expected genotype frequencies and deviations from HWE were calculated from the prevalence data for the <italic>MTHFR </italic>677 and <italic>TYMS </italic>5'UTR loci in 2898 samples that were simultaneously genotyped at both loci</p></table-wrap-foot></table-wrap><p>We observed that the proportion of individuals who are homozygous for the <italic>TYMS </italic>2R allele is different in the two groups of homozygotes for the <italic>MTHFR </italic>677; the proportion of individuals who are homozygous for the 2R allele of the 5'UTR <italic>TYMS </italic>polymorphism in individuals with the C&#x0003e;T allele of <italic>MTHFR </italic>677 is less than the proportion of individuals who are homozygous for the 2R allele in homozygotes for the C allele of <italic>MTHFR </italic>677 (see figure <xref ref-type="fig" rid="F1">1</xref>). We first made this observation in the elderly Norfolk cohorts 1 and 2. Therefore, to test if this observation was a real phenomenon, we analysed the <italic>MTHFR </italic>and <italic>TYMS </italic>genotypes in new populations and subsequently made the same observation in Norfolk cohorts 3 and 4 and in cohort 5, the female volunteers from North Cumbria Community Genetics Project [<xref ref-type="bibr" rid="B23">23</xref>]. The observations were consistent in all populations studied.</p><fig id="F1" position="float"><label>Figure 1</label><caption><p><bold>Differences in distributions of the <italic>TYMS </italic>2R_2R homozygous genotype for each of the homozygous <italic>MTHFR </italic>genotypes</bold>.</p></caption><graphic xlink:href="1471-2350-11-18-1"/></fig></sec><sec><title>Statistics</title><p>We found for all populations tested that the proportion of individuals who are homozygous for the <italic>TYMS </italic>2R allele was lower in the TT homozygotes for <italic>MTHFR </italic>677 than the CC homozygotes, but the individual tests were not significant (Table <xref ref-type="table" rid="T3">3</xref>). The consensus combined p-value test [<xref ref-type="bibr" rid="B23">23</xref>] was significant (p = 0.02). Removing the hypothesis-generating cohorts 1 and 2 from the analysis, the consensus p-value was still significant (p = 0.04) for cohorts 3, 4 and 5 only.</p><table-wrap id="T3" position="float"><label>Table 3</label><caption><p>Distribution of <italic>TYMS </italic>homozygote status for <italic>MTHFR </italic>homozygotes</p></caption><table frame="hsides" rules="groups"><tbody><tr><td/><td align="center" colspan="10"><bold><italic>TYMS</italic></bold></td></tr><tr><td/><td colspan="2"><hr/></td><td colspan="2"><hr/></td><td colspan="2"><hr/></td><td colspan="2"><hr/></td><td colspan="2"><hr/></td></tr><tr><td/><td align="center" colspan="2"><bold>Cohort 1</bold></td><td align="center" colspan="2"><bold>Cohort 2</bold></td><td align="center" colspan="2"><bold>Cohort 3</bold></td><td align="center" colspan="2"><bold>Cohort 4</bold></td><td align="center" colspan="2"><bold>Cohort 5</bold></td></tr><tr><td align="left"><bold><italic>MTHFR</italic></bold></td><td align="center"><bold><italic>2_2</italic></bold></td><td align="center"><bold><italic>Other</italic></bold></td><td align="center"><bold><italic>2_2</italic></bold></td><td align="center"><bold><italic>Other</italic></bold></td><td align="center"><bold><italic>2_2</italic></bold></td><td align="center"><bold><italic>Other</italic></bold></td><td align="center"><bold><italic>2_2</italic></bold></td><td align="center"><bold><italic>Other</italic></bold></td><td align="center"><bold><italic>2_2</italic></bold></td><td align="center"><bold><italic>Other</italic></bold></td></tr><tr><td colspan="1"><hr/></td><td colspan="2"><hr/></td><td colspan="2"><hr/></td><td colspan="2"><hr/></td><td colspan="2"><hr/></td><td colspan="2"><hr/></td></tr><tr><td align="left"><italic>CC</italic></td><td align="left">131</td><td align="left">355</td><td align="left">50</td><td align="left">156</td><td align="left">53</td><td align="left">126</td><td align="left">39</td><td align="left">127</td><td align="left">41</td><td align="left">144</td></tr><tr><td align="left"><italic>TT</italic></td><td align="left">27</td><td align="left">101</td><td align="left">9</td><td align="left">32</td><td align="left">10</td><td align="left">42</td><td align="left">4</td><td align="left">26</td><td align="left">13</td><td align="left">63</td></tr><tr><td colspan="1"><hr/></td><td colspan="2"><hr/></td><td colspan="2"><hr/></td><td colspan="2"><hr/></td><td colspan="2"><hr/></td><td colspan="2"><hr/></td></tr><tr><td align="left"><italic>P</italic>*</td><td/><td align="left">0.11</td><td/><td align="left">0.46</td><td/><td align="left">0.09</td><td/><td align="left">0.16</td><td/><td align="left">0.23</td></tr><tr><td align="left" colspan="11"><italic>Consensus P</italic><sup>&#x02020; </sup>0.02 (all cohorts), 0.04 (cohorts 3, 4 and 5 only)</td></tr></tbody></table><table-wrap-foot><p>* One-sided Fisher's exact test</p><p><sup>&#x02020; </sup>Obtained using Stouffer's consensus combined P-value test [<xref ref-type="bibr" rid="B24">24</xref>]</p></table-wrap-foot></table-wrap></sec></sec><sec><title>Discussion</title><p>We have observed a consistent gene-gene interaction in 5 different cohorts. Certain genotypes are differentially represented in these populations and this could be evidence of genetic selection during early development; in gamete formation or <italic>in utero</italic>, with some gametes or pregnancies more or less viable because of variation in the way folate is handled at the cellular level, the metabolism of folate being the link between these enzymes and their genetic loci.</p><p>There is published evidence for significant genome-wide transmission distortion [<xref ref-type="bibr" rid="B25">25</xref>] which could be caused by genetic and/or environmental influences on gamete selection and embryo viability. Ebisch <italic>et al </italic>demonstrated that sperm concentration can be raised with folic acid and zinc sulphate supplementation, but only in males who are homozygous for the 677C genotype [<xref ref-type="bibr" rid="B26">26</xref>]. Lucock and Yates have hypothesised that when folate levels are unrestricted, there is a survival advantage <italic>in utero </italic>for homozygotes for the 677C&#x0003e;T allele because that genotype will increase the levels of 5,10 methylene tetrahydrofolate favouring DNA synthesis and stability [<xref ref-type="bibr" rid="B12">12</xref>]. The investigations by Mayor-Olea <italic>et al </italic>found that the wild type, 677CC, genotype is almost absent in spontaneous abortions suggesting that this genotype may protect against pregnancy loss. However, they also interpret the increase in the prevalence of the T allele alongside the use of peri-conceptional folic acid as an indication that an environmental factor can lead to the genetic selection for the T allele or permit the survival of deleterious genotypes [<xref ref-type="bibr" rid="B13">13</xref>].</p><p>Our observation could not be caused by any simple genotyping error because the relationship observed between <italic>MTHFR </italic>and <italic>TYMS </italic>is independent of heterogeneity in the allele frequencies for the individual polymorphisms between the cohorts. During the course of these experiments we investigated the possibility of technical artefacts because it can be seen from table <xref ref-type="table" rid="T2">2</xref> that some of the individual gene frequencies were out of HWE (see <italic>MTHFR </italic>frequency for cohort 4 and <italic>TYMS </italic>frequencies for cohorts 1 and 3) and genotyping errors could explain this. Undigested PCR product in the analysis of the <italic>MTHFR </italic>677 polymorphism, and preferential amplification of the <italic>TYMS </italic>allele with 2 rather than 3 repeats could produce erroneous data for the individual genotypes. Although only a single laboratory assay was used for each genotype analysis, the DNA quality and data interpretation checks described in the methods provide confidence in the reproducibility of our methods. Futhermore, while genotyping errors could result in perturbation of HWE they would not generate the significant co-segregation of <italic>MTHFR </italic>and <italic>TYMS </italic>genotypes described.</p><p>Deviation from HWE is also possible if there are selective advantages for particular genotypes. A selective advantage for particular <italic>MTHFR </italic>genotypes could lead to deviations from HWE in the general population; heterozygote advantage occurs when environmental situations lead to heterozygous individuals for some disease alleles having increased fitness over both homozygous genotypes. In the older cohorts (1, 2 and 4) in this study both homozygous groups showed a reduced fitness relative to the heterozygotes for <italic>MTHFR </italic>677 (see table <xref ref-type="table" rid="T2">2</xref>). We and others have previously found evidence for depletion of individuals homozygous for the <italic>MTHFR </italic>677C&#x0003e;T relative to younger cohorts, and postulated it to be due to genotype-specific fatal disease [<xref ref-type="bibr" rid="B18">18</xref>-<xref ref-type="bibr" rid="B20">20</xref>,<xref ref-type="bibr" rid="B24">24</xref>]. However, given that the interaction between <italic>MTHFR </italic>and <italic>TYMS </italic>is found in all age groups, this interaction cannot be interpreted as an age-related survival factor; i.e. the death of some individuals from genotype-specific fatal disease does not explain the observation.</p><p>Given that all of the subjects from our study were born before the influence of folate related public health initiatives, could B-vitamin supplementation affect the biological phenomena that we and others have described? Haggarty <italic>et al </italic>report that folic acid intervention has not resulted in genetic selection in favour of the <italic>MTHFR </italic>677T allele [<xref ref-type="bibr" rid="B27">27</xref>], however this does not take into account potential gene-gene interactions at other folate-related loci and does not discount the possibility that numerous genetic variants may act in concert to exert selective pressure.</p></sec><sec><title>Conclusions</title><p>Our data may suggest a gene-gene interaction and could be evidence of genetic selection, with some pregnancies more or less viable as a consequence of genetic variation. If these genetic phenomena affect the way folate is handled at the cellular level <italic>in utero </italic>it is possible that maternal folic acid intake may over-ride such genetic selection. Our findings should now be tested in independent population cohorts.</p></sec><sec><title>Abbreviations</title><p>HUGO: approved nomenclature used for the gene loci; CBS: cystathionine-beta-synthase; <italic>FOLH1</italic>: folate hydrolase (prostate-specific membrane antigen) 1; <italic>MTHFR</italic>: 5,10-methylenetetrahydrofolate reductase (NADPH); <italic>MTRR</italic>: methyltetrahydrofolate-homocysteine methyltransferase reductase; <italic>TYMS</italic>: thymidylate synthetase; HWE: Hardy-Weinberg Equilibrium.</p></sec><sec><title>Competing interests</title><p>The authors declare that they have no competing interests.</p></sec><sec><title>Authors' contributions</title><p>GW, BJ and CR participated in the design of the study and contributed to the drafting or preparation of the manuscript. GW designed and optimised most of the PCR assays, collected and analysed most of the data. BJ also analysed the PCR data. CR also analysed the genotyping data by HWE. JS advised on and completed the statistical analyses. All authors contributed to and approved the final manuscript.</p></sec><sec><title>Pre-publication history</title><p>The pre-publication history for this paper can be accessed here:</p><p><ext-link ext-link-type="uri" xlink:href="http://www.biomedcentral.com/1471-2350/11/18/prepub">http://www.biomedcentral.com/1471-2350/11/18/prepub</ext-link></p></sec></body><back><sec><title>Acknowledgements</title><p>The funding for this study came from the University of East Anglia. Della Heron carried out most of the DNA extractions and gave technical assistance.</p></sec><ref-list><ref id="B1"><mixed-citation publication-type="journal"><name><surname>Wald</surname><given-names>DS</given-names></name><name><surname>Law</surname><given-names>M</given-names></name><name><surname>Morris</surname><given-names>JK</given-names></name><article-title>Homocysteine and cardiovascular disease: evidence on causality from a meta-analysis</article-title><source>Bmj</source><year>2002</year><volume>325</volume><issue>7374</issue><fpage>1202</fpage><pub-id pub-id-type="doi">10.1136/bmj.325.7374.1202</pub-id><pub-id pub-id-type="pmid">12446535</pub-id></mixed-citation></ref><ref id="B2"><mixed-citation publication-type="journal"><name><surname>Kirke</surname><given-names>PN</given-names></name><name><surname>Mills</surname><given-names>JL</given-names></name><name><surname>Molloy</surname><given-names>AM</given-names></name><name><surname>Brody</surname><given-names>LC</given-names></name><name><surname>O'Leary</surname><given-names>VB</given-names></name><name><surname>Daly</surname><given-names>L</given-names></name><name><surname>Murray</surname><given-names>S</given-names></name><name><surname>Conley</surname><given-names>M</given-names></name><name><surname>Mayne</surname><given-names>PD</given-names></name><name><surname>Smith</surname><given-names>O</given-names></name><article-title>Impact of the MTHFR C677T polymorphism on risk of neural tube defects: case-control study</article-title><source>Bmj</source><year>2004</year><volume>328</volume><issue>7455</issue><fpage>1535</fpage><lpage>1536</lpage><pub-id pub-id-type="doi">10.1136/bmj.38036.646030.EE</pub-id><pub-id pub-id-type="pmid">15155469</pub-id></mixed-citation></ref><ref id="B3"><mixed-citation publication-type="journal"><name><surname>Shields</surname><given-names>DC</given-names></name><name><surname>Kirke</surname><given-names>PN</given-names></name><name><surname>Mills</surname><given-names>JL</given-names></name><name><surname>Ramsbottom</surname><given-names>D</given-names></name><name><surname>Molloy</surname><given-names>AM</given-names></name><name><surname>Burke</surname><given-names>H</given-names></name><name><surname>Weir</surname><given-names>DG</given-names></name><name><surname>Scott</surname><given-names>JM</given-names></name><name><surname>Whitehead</surname><given-names>AS</given-names></name><article-title>The "thermolabile" variant of methylenetetrahydrofolate reductase and neural tube defects: An evaluation of genetic risk and the relative importance of the genotypes of the embryo and the mother</article-title><source>Am J Hum Genet</source><year>1999</year><volume>64</volume><issue>4</issue><fpage>1045</fpage><lpage>1055</lpage><pub-id pub-id-type="doi">10.1086/302310</pub-id><pub-id pub-id-type="pmid">10090889</pub-id></mixed-citation></ref><ref id="B4"><mixed-citation publication-type="journal"><name><surname>Hobbs</surname><given-names>CA</given-names></name><name><surname>Sherman</surname><given-names>SL</given-names></name><name><surname>Yi</surname><given-names>P</given-names></name><name><surname>Hopkins</surname><given-names>SE</given-names></name><name><surname>Torfs</surname><given-names>CP</given-names></name><name><surname>Hine</surname><given-names>RJ</given-names></name><name><surname>Pogribna</surname><given-names>M</given-names></name><name><surname>Rozen</surname><given-names>R</given-names></name><name><surname>James</surname><given-names>SJ</given-names></name><article-title>Polymorphisms in genes involved in folate metabolism as maternal risk factors for Down syndrome</article-title><source>Am J Hum Genet</source><year>2000</year><volume>67</volume><issue>3</issue><fpage>623</fpage><lpage>630</lpage><pub-id pub-id-type="doi">10.1086/303055</pub-id><pub-id pub-id-type="pmid">10930360</pub-id></mixed-citation></ref><ref id="B5"><mixed-citation publication-type="journal"><name><surname>Lucock</surname><given-names>M</given-names></name><article-title>Is folic acid the ultimate functional food component for disease prevention?</article-title><source>Bmj</source><year>2004</year><volume>328</volume><issue>7433</issue><fpage>211</fpage><lpage>214</lpage><pub-id pub-id-type="doi">10.1136/bmj.328.7433.211</pub-id><pub-id pub-id-type="pmid">14739191</pub-id></mixed-citation></ref><ref id="B6"><mixed-citation publication-type="book"><collab>Department of Health</collab><source>Report on health social subjects. 50. Folic acid and the prevention of disease. Report of the Committee on Medical Aspects of Food and Nutrition Policy</source><year>2000</year><publisher-name>London: The Stationary Office</publisher-name></mixed-citation></ref><ref id="B7"><mixed-citation publication-type="journal"><name><surname>Relton</surname><given-names>CL</given-names></name><name><surname>Wilding</surname><given-names>CS</given-names></name><name><surname>Pearce</surname><given-names>MS</given-names></name><name><surname>Laffling</surname><given-names>AJ</given-names></name><name><surname>Jonas</surname><given-names>PA</given-names></name><name><surname>Lynch</surname><given-names>SA</given-names></name><name><surname>Tawn</surname><given-names>EJ</given-names></name><name><surname>Burn</surname><given-names>J</given-names></name><article-title>Gene-gene interaction in folate-related genes and risk of neural tube defects in a UK population</article-title><source>J Med Genet</source><year>2004</year><volume>41</volume><issue>4</issue><fpage>256</fpage><lpage>260</lpage><pub-id pub-id-type="doi">10.1136/jmg.2003.010694</pub-id><pub-id pub-id-type="pmid">15060097</pub-id></mixed-citation></ref><ref id="B8"><mixed-citation publication-type="journal"><name><surname>Haggarty</surname><given-names>P</given-names></name><name><surname>McCallum</surname><given-names>H</given-names></name><name><surname>McBain</surname><given-names>H</given-names></name><name><surname>Andrews</surname><given-names>K</given-names></name><name><surname>Duthie</surname><given-names>S</given-names></name><name><surname>McNeill</surname><given-names>G</given-names></name><name><surname>Templeton</surname><given-names>A</given-names></name><name><surname>Haites</surname><given-names>N</given-names></name><name><surname>Campbell</surname><given-names>D</given-names></name><name><surname>Bhattacharya</surname><given-names>S</given-names></name><article-title>Effect of B vitamins and genetics on success of in-vitro fertilisation: prospective cohort study</article-title><source>Lancet</source><year>2006</year><volume>367</volume><issue>9521</issue><fpage>1513</fpage><lpage>1519</lpage><pub-id pub-id-type="doi">10.1016/S0140-6736(06)68651-0</pub-id><pub-id pub-id-type="pmid">16679164</pub-id></mixed-citation></ref><ref id="B9"><mixed-citation publication-type="journal"><name><surname>Boxmeer</surname><given-names>JC</given-names></name><name><surname>Macklon</surname><given-names>NS</given-names></name><name><surname>Lindemans</surname><given-names>J</given-names></name><name><surname>Beckers</surname><given-names>NG</given-names></name><name><surname>Eijkemans</surname><given-names>MJ</given-names></name><name><surname>Laven</surname><given-names>JS</given-names></name><name><surname>Steegers</surname><given-names>EA</given-names></name><name><surname>Steegers-Theunissen</surname><given-names>RP</given-names></name><article-title>IVF outcomes are associated with biomarkers of the homocysteine pathway in monofollicular fluid</article-title><source>Hum Reprod</source><year>2009</year><volume>24</volume><issue>5</issue><fpage>1059</fpage><lpage>1066</lpage><pub-id pub-id-type="doi">10.1093/humrep/dep009</pub-id><pub-id pub-id-type="pmid">19221098</pub-id></mixed-citation></ref><ref id="B10"><mixed-citation publication-type="journal"><name><surname>Nelen</surname><given-names>WL</given-names></name><name><surname>Blom</surname><given-names>HJ</given-names></name><name><surname>Steegers</surname><given-names>EA</given-names></name><name><surname>den Heijer</surname><given-names>M</given-names></name><name><surname>Eskes</surname><given-names>TK</given-names></name><article-title>Hyperhomocysteinemia and recurrent early pregnancy loss: a meta-analysis</article-title><source>Fertil Steril</source><year>2000</year><volume>74</volume><issue>6</issue><fpage>1196</fpage><lpage>1199</lpage><pub-id pub-id-type="doi">10.1016/S0015-0282(00)01595-8</pub-id><pub-id pub-id-type="pmid">11119750</pub-id></mixed-citation></ref><ref id="B11"><mixed-citation publication-type="journal"><name><surname>Verkleij-Hagoort</surname><given-names>A</given-names></name><name><surname>Bliek</surname><given-names>J</given-names></name><name><surname>Sayed-Tabatabaei</surname><given-names>F</given-names></name><name><surname>Ursem</surname><given-names>N</given-names></name><name><surname>Steegers</surname><given-names>E</given-names></name><name><surname>Steegers-Theunissen</surname><given-names>R</given-names></name><article-title>Hyperhomocysteinemia and MTHFR polymorphisms in association with orofacial clefts and congenital heart defects: a meta-analysis</article-title><source>Am J Med Genet A</source><year>2007</year><volume>143A</volume><issue>9</issue><fpage>952</fpage><lpage>960</lpage><pub-id pub-id-type="doi">10.1002/ajmg.a.31684</pub-id><pub-id pub-id-type="pmid">17431894</pub-id></mixed-citation></ref><ref id="B12"><mixed-citation publication-type="journal"><name><surname>Lucock</surname><given-names>M</given-names></name><name><surname>Yates</surname><given-names>Z</given-names></name><article-title>Folic acid - vitamin and panacea or genetic time bomb?</article-title><source>Nat Rev Genet</source><year>2005</year><volume>6</volume><issue>3</issue><fpage>235</fpage><lpage>240</lpage><pub-id pub-id-type="doi">10.1038/nrg1558</pub-id><pub-id pub-id-type="pmid">15738964</pub-id></mixed-citation></ref><ref id="B13"><mixed-citation publication-type="journal"><name><surname>Mayor-Olea</surname><given-names>A</given-names></name><name><surname>Callejon</surname><given-names>G</given-names></name><name><surname>Palomares</surname><given-names>AR</given-names></name><name><surname>Jimenez</surname><given-names>AJ</given-names></name><name><surname>Gaitan</surname><given-names>MJ</given-names></name><name><surname>Rodriguez</surname><given-names>A</given-names></name><name><surname>Ruiz</surname><given-names>M</given-names></name><name><surname>Reyes-Engel</surname><given-names>A</given-names></name><article-title>Human genetic selection on the MTHFR 677C&#x0003e;T polymorphism</article-title><source>BMC Med Genet</source><year>2008</year><volume>9</volume><issue>1</issue><fpage>104</fpage><pub-id pub-id-type="doi">10.1186/1471-2350-9-104</pub-id><pub-id pub-id-type="pmid">19040733</pub-id></mixed-citation></ref><ref id="B14"><mixed-citation publication-type="journal"><name><surname>Bailey</surname><given-names>LB</given-names></name><name><surname>Gregory</surname><given-names>JF</given-names></name><article-title>Polymorphisms of methylenetetrahydrofolate reductase and other enzymes: metabolic significance, risks and impact on folate requirement</article-title><source>J Nutr</source><year>1999</year><volume>129</volume><issue>5</issue><fpage>919</fpage><lpage>922</lpage><pub-id pub-id-type="pmid">10222379</pub-id></mixed-citation></ref><ref id="B15"><mixed-citation publication-type="journal"><name><surname>Botto</surname><given-names>LD</given-names></name><name><surname>Yang</surname><given-names>Q</given-names></name><article-title>5,10-Methylenetetrahydrofolate reductase gene variants and congenital anomalies: a HuGE review</article-title><source>Am J Epidemiol</source><year>2000</year><volume>151</volume><issue>9</issue><fpage>862</fpage><lpage>877</lpage><pub-id pub-id-type="pmid">10791559</pub-id></mixed-citation></ref><ref id="B16"><mixed-citation publication-type="journal"><name><surname>Wilding</surname><given-names>CS</given-names></name><name><surname>Relton</surname><given-names>CL</given-names></name><name><surname>Sutton</surname><given-names>MJ</given-names></name><name><surname>Jonas</surname><given-names>PA</given-names></name><name><surname>Lynch</surname><given-names>SA</given-names></name><name><surname>Tawn</surname><given-names>EJ</given-names></name><name><surname>Burn</surname><given-names>J</given-names></name><article-title>Thymidylate synthase repeat polymorphisms and risk of neural tube defects in a population from the northern United Kingdom</article-title><source>Birth Defects Res A Clin Mol Teratol</source><year>2004</year><volume>70</volume><issue>7</issue><fpage>483</fpage><lpage>485</lpage><pub-id pub-id-type="doi">10.1002/bdra.20038</pub-id><pub-id pub-id-type="pmid">15259039</pub-id></mixed-citation></ref><ref id="B17"><mixed-citation publication-type="journal"><name><surname>Trinh</surname><given-names>BN</given-names></name><name><surname>Ong</surname><given-names>CN</given-names></name><name><surname>Coetzee</surname><given-names>GA</given-names></name><name><surname>Yu</surname><given-names>MC</given-names></name><name><surname>Laird</surname><given-names>PW</given-names></name><article-title>Thymidylate synthase: a novel genetic determinant of plasma homocysteine and folate levels</article-title><source>Hum Genet</source><year>2002</year><volume>111</volume><issue>3</issue><fpage>299</fpage><lpage>302</lpage><pub-id pub-id-type="doi">10.1007/s00439-002-0779-2</pub-id><pub-id pub-id-type="pmid">12215845</pub-id></mixed-citation></ref><ref id="B18"><mixed-citation publication-type="journal"><name><surname>Heijmans</surname><given-names>BT</given-names></name><name><surname>Gussekloo</surname><given-names>J</given-names></name><name><surname>Kluft</surname><given-names>C</given-names></name><name><surname>Droog</surname><given-names>S</given-names></name><name><surname>Lagaay</surname><given-names>AM</given-names></name><name><surname>Knook</surname><given-names>DL</given-names></name><name><surname>Westendorp</surname><given-names>RG</given-names></name><name><surname>Slagboom</surname><given-names>EP</given-names></name><article-title>Mortality risk in men is associated with a common mutation in the methylene-tetrahydrofolate reductase gene (MTHFR)</article-title><source>Eur J Hum Genet</source><year>1999</year><volume>7</volume><issue>2</issue><fpage>197</fpage><lpage>204</lpage><pub-id pub-id-type="doi">10.1038/sj.ejhg.5200283</pub-id><pub-id pub-id-type="pmid">10196703</pub-id></mixed-citation></ref><ref id="B19"><mixed-citation publication-type="journal"><name><surname>Faure-Delanef</surname><given-names>L</given-names></name><name><surname>Quere</surname><given-names>I</given-names></name><name><surname>Chasse</surname><given-names>JF</given-names></name><name><surname>Guerassimenko</surname><given-names>O</given-names></name><name><surname>Lesaulnier</surname><given-names>M</given-names></name><name><surname>Bellet</surname><given-names>H</given-names></name><name><surname>Zittoun</surname><given-names>J</given-names></name><name><surname>Kamoun</surname><given-names>P</given-names></name><name><surname>Cohen</surname><given-names>D</given-names></name><article-title>Methylenetetrahydrofolate reductase thermolabile variant and human longevity</article-title><source>Am J Hum Genet</source><year>1997</year><volume>60</volume><issue>4</issue><fpage>999</fpage><lpage>1001</lpage><pub-id pub-id-type="pmid">9106548</pub-id></mixed-citation></ref><ref id="B20"><mixed-citation publication-type="journal"><name><surname>Jennings</surname><given-names>BA</given-names></name><name><surname>Wimperis</surname><given-names>JZ</given-names></name><name><surname>Tickner</surname><given-names>T</given-names></name><name><surname>Naidu</surname><given-names>R</given-names></name><name><surname>Willis</surname><given-names>G</given-names></name><article-title>MTHFR 677 polymorphism in an elderly patient cohort</article-title><source>European Journal of Human Genetics</source><year>2003</year><volume>11</volume><fpage>S249</fpage></mixed-citation></ref><ref id="B21"><mixed-citation publication-type="journal"><name><surname>Roe</surname><given-names>MA</given-names></name><name><surname>Heath</surname><given-names>AL</given-names></name><name><surname>Oyston</surname><given-names>SL</given-names></name><name><surname>Macrow</surname><given-names>C</given-names></name><name><surname>Hoogewerff</surname><given-names>JA</given-names></name><name><surname>Foxall</surname><given-names>R</given-names></name><name><surname>Dainty</surname><given-names>JR</given-names></name><name><surname>Majsak-Newman</surname><given-names>G</given-names></name><name><surname>Willis</surname><given-names>G</given-names></name><name><surname>Fairweather-Tait</surname><given-names>SJ</given-names></name><article-title>Iron absorption in male C282Y heterozygotes</article-title><source>Am J Clin Nutr</source><year>2005</year><volume>81</volume><issue>4</issue><fpage>814</fpage><lpage>821</lpage><pub-id pub-id-type="pmid">15817857</pub-id></mixed-citation></ref><ref id="B22"><mixed-citation publication-type="journal"><name><surname>Khandanpour</surname><given-names>N</given-names></name><name><surname>Willis</surname><given-names>G</given-names></name><name><surname>Meyer</surname><given-names>FJ</given-names></name><name><surname>Armon</surname><given-names>MP</given-names></name><name><surname>Loke</surname><given-names>YK</given-names></name><name><surname>Wright</surname><given-names>AJ</given-names></name><name><surname>Finglas</surname><given-names>PM</given-names></name><name><surname>Jennings</surname><given-names>BA</given-names></name><article-title>Peripheral arterial disease and methylenetetrahydrofolate reductase (MTHFR) C677T mutations: A case-control study and meta-analysis</article-title><source>J Vasc Surg</source><year>2009</year><volume>49</volume><issue>3</issue><fpage>711</fpage><lpage>718</lpage><pub-id pub-id-type="doi">10.1016/j.jvs.2008.10.004</pub-id><pub-id pub-id-type="pmid">19157768</pub-id></mixed-citation></ref><ref id="B23"><mixed-citation publication-type="journal"><name><surname>Chase</surname><given-names>DS</given-names></name><name><surname>Tawn</surname><given-names>EJ</given-names></name><name><surname>Parker</surname><given-names>L</given-names></name><name><surname>Jonas</surname><given-names>P</given-names></name><name><surname>Parker</surname><given-names>CO</given-names></name><name><surname>Burn</surname><given-names>J</given-names></name><article-title>The North Cumbria Community Genetics Project</article-title><source>J Med Genet</source><year>1998</year><volume>35</volume><issue>5</issue><fpage>413</fpage><lpage>416</lpage><pub-id pub-id-type="doi">10.1136/jmg.35.5.413</pub-id><pub-id pub-id-type="pmid">9610806</pub-id></mixed-citation></ref><ref id="B24"><mixed-citation publication-type="journal"><name><surname>Rice</surname><given-names>WR</given-names></name><article-title>A Consensus Combined P-Value Test and the Family-Wide Significance of Component Tests</article-title><source>Biometrics</source><year>1990</year><volume>46</volume><issue>2</issue><fpage>303</fpage><lpage>308</lpage><pub-id pub-id-type="doi">10.2307/2531435</pub-id></mixed-citation></ref><ref id="B25"><mixed-citation publication-type="journal"><name><surname>Zollner</surname><given-names>S</given-names></name><name><surname>Wen</surname><given-names>X</given-names></name><name><surname>Hanchard</surname><given-names>NA</given-names></name><name><surname>Herbert</surname><given-names>MA</given-names></name><name><surname>Ober</surname><given-names>C</given-names></name><name><surname>Pritchard</surname><given-names>JK</given-names></name><article-title>Evidence for extensive transmission distortion in the human genome</article-title><source>Am J Hum Genet</source><year>2004</year><volume>74</volume><issue>1</issue><fpage>62</fpage><lpage>72</lpage><pub-id pub-id-type="doi">10.1086/381131</pub-id><pub-id pub-id-type="pmid">14681832</pub-id></mixed-citation></ref><ref id="B26"><mixed-citation publication-type="journal"><name><surname>Ebisch</surname><given-names>IM</given-names></name><name><surname>van Heerde</surname><given-names>WL</given-names></name><name><surname>Thomas</surname><given-names>CM</given-names></name><name><surname>Put</surname><given-names>N van der</given-names></name><name><surname>Wong</surname><given-names>WY</given-names></name><name><surname>Steegers-Theunissen</surname><given-names>RP</given-names></name><article-title>C677T methylenetetrahydrofolate reductase polymorphism interferes with the effects of folic acid and zinc sulfate on sperm concentration</article-title><source>Fertil Steril</source><year>2003</year><volume>80</volume><issue>5</issue><fpage>1190</fpage><lpage>1194</lpage><pub-id pub-id-type="doi">10.1016/S0015-0282(03)02157-5</pub-id><pub-id pub-id-type="pmid">14607573</pub-id></mixed-citation></ref><ref id="B27"><mixed-citation publication-type="journal"><name><surname>Haggarty</surname><given-names>P</given-names></name><name><surname>Campbell</surname><given-names>DM</given-names></name><name><surname>Duthie</surname><given-names>S</given-names></name><name><surname>Andrews</surname><given-names>K</given-names></name><name><surname>Hoad</surname><given-names>G</given-names></name><name><surname>Piyathilake</surname><given-names>C</given-names></name><name><surname>Fraser</surname><given-names>I</given-names></name><name><surname>McNeill</surname><given-names>G</given-names></name><article-title>Folic acid use in pregnancy and embryo selection</article-title><source>Bjog</source><year>2008</year><volume>115</volume><issue>7</issue><fpage>851</fpage><lpage>856</lpage><pub-id pub-id-type="pmid">18485163</pub-id></mixed-citation></ref></ref-list></back></article>